梁泰剛

教授,，醫(yī)學(xué)博士,，博士生導(dǎo)師,，山西醫(yī)科大學(xué)藥學(xué)院副院長(zhǎng)

E-mail:[email protected]

個(gè)人主頁(yè)或網(wǎng)站：https://www.researchgate.net/profile/Taigang-Liang

工作經(jīng)歷

2019.12-今山西醫(yī)科大學(xué)藥學(xué)院 副院長(zhǎng),，博士生導(dǎo)師,，教授

2017.02-2019.12山西省繁峙縣科技副縣長(zhǎng)（掛職）

2015.12-2017.02山西醫(yī)科大學(xué)藥學(xué)院教授

2010.12-2015.12山西醫(yī)科大學(xué)藥學(xué)院副教授

2005.12-2010.12山西醫(yī)科大學(xué)藥學(xué)院講師

2003.07-2005.12山西醫(yī)科大學(xué)藥學(xué)院助教

學(xué)術(shù)任職

山西省藥學(xué)會(huì)藥物化學(xué)專業(yè)委員會(huì)主任委員,，山西省藥學(xué)會(huì)第六屆理事會(huì)理事

榮譽(yù)獲獎(jiǎng)

山西省高等學(xué)校優(yōu)秀青年學(xué)術(shù)帶頭人,、山西省高等學(xué)?！?31”領(lǐng)軍人才和“三晉英才”,。長(zhǎng)期從事中西藥基礎(chǔ)與產(chǎn)業(yè)化研究,。主持國(guó)家自然科學(xué)基金等各類(lèi)課題10余項(xiàng)。近年來(lái)以第一作者/通訊作者發(fā)表學(xué)術(shù)論文50余篇,，其中SCI收錄20余篇,。授權(quán)發(fā)明專利3項(xiàng)，開(kāi)發(fā)2種中藥新產(chǎn)品,、1種保健酒上市銷(xiāo)售,。榮獲山西省科學(xué)技術(shù)獎(jiǎng)二等獎(jiǎng)3項(xiàng),，山西省高校科技進(jìn)步一等獎(jiǎng)4項(xiàng),。

代表性論文

(1) Chaoqun Yan; Xiaoyan Zhang; Junqiu Miao; Hongxia Yuan,；Enli Liu；Taigang Liang*; Qingshan Li*; Farrerol directly targets GSK-3β to activate Nrf2-ARE pathway and protect EA.hy926 cells against oxidative stress-induced injuries,Oxidative Medicine and Cellular Longevity, 2020, 2020.（2區(qū),，IF=4.936）

(2) Dongxiao Cui; Jun Ma; Tingting Liang; Liqian Sun; Liqiang Meng;Taigang Liang*; Qingshan Li*, Selenium nanoparticles fabricated in laminarin polysaccharides solutions exert their cytotoxicities in HepG2 cells by inhibiting autophagy and promoting apoptosis,International Journal of Biological Macromolecules, 2019, 137: 829-835.(2區(qū),，IF=4.784)

(3) Dongxiao Cui; Chaoqun Yan; Junqiu Miao; Xiaoyan Zhang; Jingrun Chen; Liqian Sun; Liqiang Meng;Taigang Liang*; Qingshan Li*; Synthesis characterization and antitumor properties of selenium nanoparticles coupling with ferulic acid,Materials Science & Engineering C, 2018, 90: 104-112.(2區(qū)，IF=4.959)

(4) Xiue Feng^#;Taigang Liang^#; Jie Gao^#; Depeng Kong; Rui Ge; Qingshan Li*; Heme oxygenase-1, a key enzyme for the cytoprotective actions of halophenols by upregulating Nrf2 expression via activating Erk1/2 and PI3K/Akt in EA. hy926 cells,Oxidative Medicine and Cellular Longevity, 2017, 2017.（2區(qū),，IF=4.936）

(5) Xiaorui Wang; Junqiu Miao; Chaoqun Yan; Rui Ge;Taigang Liang*; Enli Liu; Qingshan Li*; Chitosan attenuates dibutyltin-induced apoptosis in PC12 cells through inhibition of the mitochondria-dependent pathway,Carbohydrate Polymers, 2016, 151: 996-1005. (2區(qū),，IF=6.044)